Can high-dose propranolol reduce severe aggression in autistic adolescents? A small pilot crossover trial suggests promising improvements, though cardiovascular monitoring remains essential. We examine the data, practical limitations, and how this approach fits into a thoughtful, stepwise treatment algorithm.